Scalper1 News
Medical product giants St. Jude Medical and Abbott Laboratories both beat analysts’ Q2 expectations and raised their guidance Wednesday, but their shares had a bumpy ride on the market amid a fresh attack on drug-industry mergers. Abbott (ABT) reported its first sales beat in six quarters. Revenue rose 2% to $5.55 billion, about $30 million above consensus. Earnings climbed 17% to 54 cents a share, beating estimates by 4 cents. The company added a Scalper1 News
Scalper1 News